15 reports

Molecular Cytogenetics market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Molecular Cytogenetics Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Molecular Cytogenetics types, applications. Further, Molecular...

  • Cytogenetic
  • World

The global molecular cytogenetics market exhibited strong growth during 2015-2020. Looking forward, the analyst expects the market to grow at a CAGR of 10.2% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the...

  • Cytogenetic
  • World

Abstract: What`s New for 2022? -Global competitiveness and key competitor percentage market shares -Market presence across multiple geographies - Strong/Active/Niche/Trivial -Online interactive peer-to-peer collaborative bespoke updates -Access to our digital archives and MarketGlass...

  • Cytogenetic
  • World
  • China
  • United States
  • Cancer Incidence

Molecular Cytogenetics Market Report Overview Molecular Cytogenetics market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Molecular Cytogenetics market types and applications. It is a focused study on Molecular Cytogenetics market space...

  • Cytogenetic
  • World
  • Health Provider Density

Abstract: What`s New for 2022? -Global competitiveness and key competitor percentage market shares -Market presence across multiple geographies - Strong/Active/Niche/Trivial -Online interactive peer-to-peer collaborative bespoke updates -Access to our digital archives and MarketGlass...

  • Cytogenetic
  • Cancer
  • World
  • Cancer Incidence

The global hematologic malignancies market exhibited strong growth during 2015-2020. Looking forward, the analyst expects the market to grow at a CAGR of around 10% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence...

  • Cancer
  • Genomics
  • Cytogenetic
  • Molecular Diagnostics
  • Leukemia
  • Diagnostics
  • Lymphoma
  • Clinical Research
  • Immunotherapy
  • World
  • Life Expectancy

This study covers the world outlook for molecular cytogenetics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These...

  • Cytogenetic
  • World
  • Gross Domestic Product
  • Disposable Income

Chronic Lymphocytic Leukemia: Epidemiology Forecast to 2027 Summary Chronic lymphocytic leukemia (CLL) (International Statistical Classification of Diseases and Related Health Problems, 10th Revision [ICD-10] code = C91.1), also known as chronic lymphoid leukemia, is a type of cancer of the white...

  • Leukemia
  • Epidemiology
  • Cytogenetic
  • World
  • Elderly Population
  • Prescription Drug Sales

Cytogenetics Market by Product (Consumables, Instruments, and Software & Services), Technique (Comparative Genomic Hybridization, Fluorescence in Situ Hybridization (FISH), Karyotyping, Immunohistochemistry, and Others), Application (Genetic Disorders, Cancer, Personalized Medicine, and Others), and End User (Clinical & Research Laboratories,...

  • Cytogenetic
  • Genetic Disorder
  • World
  • Chronic Disease Prevalence

Global molecular cytogenetics market is forecasted to attain revenue of $3.3 billion by 2023, The market is mainly driven by growing implementation of pharmacogenomics in personalized disease management and drug development, rising cancer cases, advancements in cytogenetic techniques, and rise in genetic-based prediction of chromosomal...

  • Cytogenetic
  • World
  • APAC
  • Health Expenditure

In Situ Hybridization (ISH) Market Size, Share & Trends Analysis Report By Technology (FISH, CISH), By Type (DNA, RNA) By Product (Instruments, Probes & Kits), By Application, By End Use, And Segment Forecasts, 2018 - 2025 The global in situ hybridization (ISH) market size is expected to reach USD 1.84 billion by 2025, according to...

  • Diagnostics
  • Clinical Research
  • Drug Development
  • Molecular Diagnostics
  • Cancer Diagnostics
  • Cytogenetic
  • Infectious Disease
  • Fuels
  • Genetic Disorder
  • Laboratory
  • Molecular Biology
  • World
  • APAC
  • North America
  • Fuel Demand

The molecular cytogenetics market is projected to reach USD 2.52 billion by 2021 from USD 1.55 billion in 2016, at a CAGR of 10.1% from 2016 to 2021. The global molecular cytogenetics market is segmented based on product, technique, application, end user, and region. The kits and reagents segment is expected to register the highest growth...

  • Cytogenetic
  • United States
  • World
  • Europe
  • India
  • North America
  • Asia
  • Cancer Incidence
  • Health Expenditure

Summary NeoGenomics Inc (NeoGenomics) is a specialized oncology reference laboratory that provides biopharma and other testing technologies for anatomic pathology and oncology markets. It offers testing services with various technologies such as cytogenetics, fluorescence in-situ hybridization, flow cytometry, immunohistochemistry,...

  • Pharmaceutical
  • Drug Development
  • Cytogenetic
  • Biopharmaceutical
  • Healthcare
  • Genome Sequencing
  • Clinical Trial
  • Biomarker
  • APAC
  • Europe
  • North America
  • Middle East
  • Africa

Summary Empire Genomics LLC (Genomics) is a medical device company that offers molecular diagnostic solutions. The company offers ID labs products, fish probes, BAC clones, genotyping and circulating tumor cell products. Its services comprise array CGH, gene expression, clinical and custom services. Genomics’s ID lab products...

  • Genomics
  • Cytogenetic
  • APAC
  • Europe
  • North America
  • Middle East
  • Africa

Summary MetaSystems GmbH (MetaSystems) is a medical device company that offers automated scanning and image analysis. The company’s product segments include slide scanning, karyotyping and fluorescence imaging; and DNA probe kits. Its slide scanning with Metafer and its software modules offer tools for automated analysis and...

  • Medical Equipment
  • Cytogenetic
  • Medical Device
  • APAC
  • Europe
  • North America
  • Middle East
  • Africa